Biohit Oyj

Board/Management Information • Aug 16, 2018

Disclosure 363826

Biohit Oyj - Changes board/management/auditors

Decisions of the Extraordinary General Meeting of Biohit Oyj

Biohit Oyj Decisions of the Extraordinary General Meeting 16, 2018 at 17.00 local time (EET)

Resolution on the increase the size of the Board of Directors

The Extraordinary General Meeting (EGM) of Biohit Oyj held on Thursday August 16, 2018 decided to accept the propose to increase the number of Board members.

The number shall be six (6).

Election of new member of the Board of Directors

Shareholders of Biohit Oyj, who represent more than 50% of the voting rights of the company’s shares, decided that Managing Director of Biohit HealthCare (Hefei) Co., Ltd Liu Feng is elected as new member until the end of the next Annual General Meeting on addition of the Board members, which were elected in Annual General Meeting.

More information on the new member is available on the company website at: www.biohit.fi/sijoittajat.

All decisions of the EGM were made unanimously. The minutes of the EGM will be available for review by shareholders by August 21, 2018 on the company’s website (www.biohithealthcare.com /investors) and at the corporate headquarters of Biohit, located at Laippatie 1, 00880 Helsinki.

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com